Predoctoral Training Program for Alzheimer’s Disease at the Interface of Data Science, Engineering and Biology
数据科学、工程和生物学交叉领域的阿尔茨海默病博士前培训项目
基本信息
- 批准号:10628106
- 负责人:
- 金额:$ 24.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
The overarching goal of this Training Program for predoctoral students based at the at the Rensselaer
Polytechnic Institute (RPI) is to provide cross-disciplinary training for future innovative leaders in translational
ADRD research. Our training will emphasize the application of data science and engineering principles to
ADRD biology and translational research through interdisciplinary research projects and coursework. The
proposed Training Program will provide trainees with a keen understanding of the interdisciplinary and
translational nature of ADRD research, which is firmly based on fundamental research in biological sciences,
data science and engineering, leading to innovative new scientific disciplines and technologies, novel AD drug
development, and translation of discoveries to the clinic. Training faculty are actively involved in research
programs spanning: 1) data science as applied to ADRD, including medical imaging; 2) pharmacologic
interventions for ADRD; and 3) structural biology of protein folding/tau. The Alzheimer’s Disease Research
Center (ADRC) at Icahn School of Medicine at Mount Sinai (ISMMS) will be our clinical training partner through
a subcontract and will provide ample access to educational and research opportunities to our trainees. Key
aspects of the Training Program include: [1] a set of five courses to maximize didactic training among the key
disciplines, including a new course entitled “Data Science and ADRD” and summer bootcamp “Data Science
and ADRD: Hands-on Training and Research Challenge”. Development and launch of the new data science
course and summer bootcamp have been funded by a supplement to the current NIA T32, with their inaugural
runs planned for 2022; [2] a core course entitled “Perspectives in Alzheimer’s Disease Research” that is taken
by all trainees and open to other RPI students; [3] a seminar series (Frontiers in Alzheimer’s Research) and
related research symposia that builds on campus-wide programs at RPI and clinical and industry partners; [4] a
student-run seminar program, in which trainees present their research to their peers and training faculty; [5]
training in responsible conduct of research; [6] Co-advising and multidisciplinary PhD thesis committee with
ADRD expertise; [7] translational and clinical internship at Icahn School of Medicine at Mount Sinai (ISMMS)
and industrial partners; [8] poster presentation and participation at annual meetings of the Rensselaer Center
for Biotechnology and Interdisciplinary Studies (CBIS) and Institute for Data Exploration and Applications
(IDEA); [9] entrepreneurship and commercial translation training; and [10] an annual retreat in contemporary
research in AD and related dementias at which trainees and members of the larger campus community interact
with prominent researchers in the field.
项目总结/摘要
该培训计划的首要目标是为在伦斯勒大学的博士前学生提供培训,
理工学院(RPI)是为未来的创新领导者提供跨学科的培训,
ADRD研究。我们的培训将强调数据科学和工程原理的应用,
通过跨学科研究项目和课程进行ADRD生物学和转化研究。的
拟议的培训计划将为学员提供对跨学科和跨领域的敏锐理解
ADRD研究的转化性质,牢固地建立在生物科学基础研究的基础上,
数据科学与工程,引领创新的新科学学科和技术,新型AD药物
开发,并将发现转化为临床。培训教师积极参与研究
项目涵盖:1)应用于ADRD的数据科学,包括医学成像; 2)药理学
ADRD的干预;和3)蛋白质折叠/tau的结构生物学。老年痴呆症的研究
西奈山伊坎医学院(ISMMS)的ADRC中心将成为我们的临床培训合作伙伴,
我们的培训计划将为学员提供充足的教育和研究机会。关键
培训计划的方面包括:[1]一套五门课程,以最大限度地提高教学培训的关键,
学科,包括一个名为“数据科学和ADRD”的新课程和夏令营“数据科学”
和ADRD:实践培训和研究挑战”。开发和推出新的数据科学
课程和夏季训练营已经由目前的NIA T32的补充资助,他们的就职典礼
计划于2022年运行; [2]一个名为“阿尔茨海默病研究的观点”的核心课程,
由所有学员和开放给其他RPI学生; [3]一个研讨会系列(前沿在阿尔茨海默氏症的研究)和
相关的研究座谈会,建立在校园范围内的计划在RPI和临床和行业合作伙伴; [4]
学生管理的研讨会项目,学员向同行和培训教师展示他们的研究; [5]
负责的研究行为的培训; [6]共同咨询和多学科博士论文委员会,
ADRD专业知识; [7]西奈山伊坎医学院(ISMMS)的翻译和临床实习
和工业合作伙伴; [8]伦斯勒中心年会上的海报展示和参与
生物技术和跨学科研究(CBIS)和数据探索和应用研究所
[9]创业和商业翻译培训;[10]当代艺术的年度务虚会
在AD和相关痴呆症的研究,学员和更大的校园社区的成员互动
与该领域的杰出研究人员进行交流。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chunyu Wang其他文献
Chunyu Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chunyu Wang', 18)}}的其他基金
The Alzheimer's Disease Clinical and Translational Research (ADCTR) Training Program
阿尔茨海默病临床和转化研究 (ADCTR) 培训计划
- 批准号:
10221565 - 财政年份:2017
- 资助金额:
$ 24.08万 - 项目类别:
Development of data science course and summer bootcamp for ADRD researchers
为 ADRD 研究人员开发数据科学课程和夏季训练营
- 批准号:
10405365 - 财政年份:2017
- 资助金额:
$ 24.08万 - 项目类别:
The Alzheimer's Disease Clinical and Translational Research (ADCTR) Training Program
阿尔茨海默病临床和转化研究 (ADCTR) 培训计划
- 批准号:
9977904 - 财政年份:2017
- 资助金额:
$ 24.08万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
8000230 - 财政年份:2010
- 资助金额:
$ 24.08万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7911738 - 财政年份:2007
- 资助金额:
$ 24.08万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7483631 - 财政年份:2007
- 资助金额:
$ 24.08万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7299036 - 财政年份:2007
- 资助金额:
$ 24.08万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7680970 - 财政年份:2007
- 资助金额:
$ 24.08万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
7681489 - 财政年份:2007
- 资助金额:
$ 24.08万 - 项目类别:
Testing novel hypotheses in Mtu RecA intein splicing
测试 Mtu RecA 内含肽剪接的新假设
- 批准号:
8136454 - 财政年份:2007
- 资助金额:
$ 24.08万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 24.08万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 24.08万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 24.08万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 24.08万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 24.08万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 24.08万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 24.08万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 24.08万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 24.08万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 24.08万 - 项目类别:














{{item.name}}会员




